免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Livongo 血糖監測系統 (BG1000)

K 號:K200277 · 2020-06-04

決定日期2020-06-04
產品代碼NBW
諮詢委員會CH
決定相當於

器材摘要

Livongo Blood Glucose Monitoring System (BG1000) is the device name listed in this FDA 510(k) record. The listed applicant is Livongo Health, Inc.. It received FDA 510(k) clearance on 2020-06-04 under 510(k) number K200277. The device is classified under product code NBW. It was reviewed by the CH advisory panel. Product code NBW falls under the category of OB/GYN, which includes obstetric and gynecological diagnostic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

常見問題

What is the Livongo Blood Glucose Monitoring System (BG1000)?

Livongo Blood Glucose Monitoring System (BG1000) is a medical device that received FDA 510(k) clearance on 2020-06-04. The listed applicant is Livongo Health, Inc.. The 510(k) number is K200277.

When did Livongo Blood Glucose Monitoring System (BG1000) receive FDA 510(k) clearance?

Livongo Blood Glucose Monitoring System (BG1000) received FDA 510(k) clearance on 2020-06-04, under 510(k) number K200277.

Who is the listed applicant for Livongo Blood Glucose Monitoring System (BG1000)?

The FDA 510(k) record lists Livongo Health, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Livongo Blood Glucose Monitoring System (BG1000)?

The FDA product code for Livongo Blood Glucose Monitoring System (BG1000) is NBW. This falls under the OB/GYN category.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:NBW)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑